Cross-validation of prognostic scores in myelodysplastic syndromes on 386 patients from a single institution confirms importance of cytogenetics.

M Pfeilstöcker; R Reisner; T Nösslinger; H Grüner; H Nowotny; H Tüchler; E Schlögl; E Pittermann; R Heinz

doi:10.1046/j.1365-2141.1999.01559.x

Cross-validation of prognostic scores in myelodysplastic syndromes on 386 patients from a single institution confirms importance of cytogenetics.

Identifier:nobleid.org/w1/20260515/3B6BBCC1

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/3B6BBCC1.svg?ark=w1%2F20260515%2F3B6BBCC1)](https://nobleid.org/work/w1/20260515/3B6BBCC1)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work

Cross-validation of prognostic scores in myelodysplastic syndromes on 386 patients from a single institution confirms importance of cytogenetics.

Identifier:nobleid.org/w1/20260515/3B6BBCC1

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/3B6BBCC1.svg?ark=w1%2F20260515%2F3B6BBCC1)](https://nobleid.org/work/w1/20260515/3B6BBCC1)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work